Continuing Medical Education: Urogenital Complaints and Female Sexual Dysfunction (Part 2) (CME) |
| |
| Authors: | Salim A Wehbe Susan Kellogg Kristene Whitmore |
| |
| Institution: | 2. Pelvic and Sexual Health Institute, Drexel University College of Medicine, Philadelphia, PA, USA;2. Clinical Research Center, Eastern Virginia Medical School, Norfolk, VA, USA;3. Clinique de recherche en santé des femmes, Quebec City, QCCanada;4. Diex Recherche Inc.Sherbrooke, QCCanada;5. Rapid Medical Research Inc.Cleveland, OH, USA;11. Montreal Clinical Study Center, Montreal, QCCanada;12. Centre hospitalier affilié universitaire de Québec, Quebec City, QCCanada;8. Mc, Gill University Health Center, Royal Victoria Hospital, Montreal, QCCanada;9. Veristat Inc.Boston, MA, USA;1. Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK;2. Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford Radcliffe Trust, Oxford, UK;3. Genetech Research Institute, Colombo, Sri Lanka;4. Ministry of Health Care and Nutrition, Colombo, Sri Lanka;1. Istanbul University, Istanbul Faculty of Medicine, Department of Internal Medicine, Division of Endocrinology and Metabolism, Istanbul, Turkey;2. Istanbul University, Istanbul Faculty of Medicine, Department of Pulmonary Diseases, Istanbul, Turkey;3. Istanbul University, Istanbul Faculty of Medicine, Department of Biochemistry, Istanbul, Turkey;1. Dana‐Farber Cancer Institute, Brigham and Women''s Hospital and Harvard Medical School, Boston, MA, USA;2. Department of Biostatistics and Computational Biology, Dana‐Farber Cancer Center, Boston, MA, USA;3. Harvard School of Public Health, Boston, MA, USA;1. Department of Family Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia;2. Klinik Kesihatan Bintulu, Jabatan Kesihatan Bahagian Bintulu, Lebuhraya Abang Galau, 97000 Bintulu, Sarawak, Malaysia;3. Department of Psychiatry, Faculty of Medicine, Universiti Kebangsaan Malaysia, 56000 Cheras, Kuala Lumpur, Malaysia;4. Department of Psychological Medicine, Faculty of Medicine, Universiti Malaya, Lembah Pantai, 50603 Kuala Lumpur, Malaysia;5. PAP Rashidah Sa''adatul Bolkiah Institute of Health Sciences, Universiti Brunei Darussalam, Jalan Tungku Link, BE1410, Negara Brunei Darussalam;6. Department of Anatomy, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300 Kuala Lumpur, Malaysia |
| |
| Abstract: | IntroductionFemale sexual dysfunction (FSD) is common in women with urogenital disorders that occur as a result of pelvic floor muscle and fascial laxity.AimProvide a comprehensive review of FSD as it relates to common urogenital disorders including pelvic organ prolapse (POP) and stress urinary incontinence (SUI) and to discuss the impact of the surgical repair of these disorders on sexual function.MethodsSystematic search of the medical literature using a number of related terms including FSD, POP, SUI, surgical repair, graft augmentation, complications, and dyspareunia.Main Outcome MeasuresReview of the medical literature to identify the relation between FSD and common urogenital disorders in women and to describe appropriate treatment strategies to improve quality of life (QOL) and sexual function.ResultsFSD is common in women with POP and SUI. Treatment options for POP and SUI include behavioral, pharmacological, and surgical methods which can also affect sexual function.ConclusionsSexual dysfunction is a common, underestimated complaint in women with POP and SUI. Treatment should be tailored toward improving sexual function and QOL. Surgical correction is generally beneficial but occasionally can result in negative alterations in sexual function. Patient selection and methods used for surgical repair are important factors in determining anatomical and functional success. Wehbe SA, Kellogg S, and Whitmore K. Urogenital complaints and female sexual dysfunction (part 2). |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
